A privately held pharmaceutical company with a cutting-edge approach to medication research is AKL Research & Development Limited. For inflammatory disorders with a high unmet demand, such as osteoarthritis, Alzheimer’s, rheumatoid arthritis, and the uncommon connective tissue disease scleroderma, AKLRD is researching innovative treatments.